<?xml version="1.0" encoding="UTF-8"?>
<p>We also applaud the initiativeâ€™s plans to place a greater emphasis on pharmacovigilance, given the scope of the problem of substandard and counterfeit drugs in the EAC. As mentioned above, we believe it might make sense for the initiative to allocate even more of its resources to such work and to monitor the physical quality and integrity of the drug supply, though we recognize that much of the policing of drug safety must be done by individual countries. EAC countries should also consider joining MEDICRIME, the first international treaty against falsified medical products and devices involving threats to public health. It has been ratified by 12 European countries, as well as Guinea, Burkina Faso, and Ivory Coast [
 <xref rid="pmed.1003092.ref023" ref-type="bibr">23</xref>].
</p>
